FabRx was created by leading academics at University College London (UCL), with a passion for developing better medicines using 3D printing. We believe in a world where medical treatment can be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units. In this way, medicine taking is easier, more effective and associated with better patient outcomes.
Established in 2014, FabRx is a small start-up company with a big vision. Using our patented technologies, we provide a novel and flexible platform for the production of personalised medicines, revolutionising medical treatment for patients around the world. The future of medicine is 3D.